DexCom, Inc. (NASDAQ:DXCM) Q1 2024 Earnings Call Transcript
DexCom, Inc. beats earnings expectations. Reported EPS is $0.32, expectations were $0.27. DexCom, Inc.
Dexcom Inc (DXCM)
Market is closed
News
- 1 - 10
- Next >>
14 Best 52-Week High Stocks To Invest In Now
This article delves into the examination of the 14 best 52-week high stocks to buy now.
5 Best Weight Loss Drug Stocks to Buy Now
In this piece, we will take a look at the five best weight loss drug stocks to buy now.
Should You Hold DexCom (DXCM)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Insiders Are Dumping These 5 Healthcare Stocks
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) is a clinical stage biopharma company that is working on treatments for endocrine-related diseases.
Here's What Happened to Dexcom (DXCM) Stock in Q4
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter.
14 Best Medical Device Stocks To Buy Now
In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now.
Should You Hold DexCom (DXCM) for the Long Term?
Next Century Growth Investors, LLC, an investment Management Company, released its “SMID Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Here’s Why DexCom (DXCM) Outperformed in Q4
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Most Valuable Digital Health Companies In The US
In this article, we will be talking about the 5 most valuable digital health companies in the US.
- 1 - 10
- Next >>
Billionaire Hedge Funds
